News Release
CBIO submits Form 8-K regarding its Nasdaq listing status
Please be advised that Catalyst Biosciences, Inc. (CBIO), one of our affiliates, filed 8-K to SEC today regarding its listing status at Nasdaq.
For more details, please refer to the link below.
https://ir.catalystbiosciences.com/static-files/dcdd2465-4e87-4dba-b808-71ac4f404d45
This document is created purely for the purpose of publicly announcing CBIO’s official filing with SEC and NOT for the purpose of soliciting investment either in Japan or overseas.